←
Immunai134 posts
Immunai avatar

Immunai

@Immunaitech

Decoding the Immune System to Improve Health

◷ Joined May 2020▧ 32 Photos and videos
Immunai avatar
Immunai@Immunaitech·Feb 4

World Cancer Day is about progress. And progress starts with better insight. We’re proud to work with @bmsnews to apply AI-powered immune analysis that helps researchers better understand patient responses and support smarter therapy development. tinyurl.com/bde5uc8w

Immunai avatar
Immunai@Immunaitech·20 Nov 2025

Big news: @Immunai has won the @FierceBiotech Life Sciences Award for AI Innovation. Fierce showcased our AMICA™ platform and its success in forecasting patient response - a major step toward more precise development. tinyurl.com/3z65bp5f

Immunai avatar
Immunai@Immunaitech·3 Nov 2025

Immunai has been named a finalist in the @FierceHealth : Life Sciences Edition 2025 (AI Innovation category)! Our AMICA™, CT-OS™, and PE-OS™ platforms are driving a new wave of immune intelligence, where AI helps predict, not just treat, disease. bit.ly/3J1qPUc

Post attachment
Immunai avatar
Immunai@Immunaitech·16 Oct 2025

Proud to expand our work with @AstraZeneca into inflammatory bowel disease. IBD affects 10M+ people worldwide, with many still cycling through treatments. With Immunai’s IDE™ and AMICA™, we’re uncovering and exploring new immune targets. @FierceBiotech: tinyurl.com/48htfzzy

Immunai avatar
Immunai@Immunaitech·4 Sep 2025

Research in immunity can’t wait for funding. We launched the Grand Collaboration Initiative to give researchers free access to immune mapping tools: accelerating discoveries in cancer, autoimmunity, and beyond. More in @PharmaVoice tinyurl.com/mr455nr8

Immunai avatar
Immunai@Immunaitech·2 Sep 2025

Research in immunity can’t wait for funding. Immunai’s Grand Collaboration Initiative is giving researchers free access to our immune mapping tools to speed discoveries in cancer, autoimmunity, and more. tinyurl.com/3k3mk5j8

Immunai avatar
Immunai@Immunaitech·24 Jul 2025

Immunai’s Grand Collaboration is now open! Single-cell immune sequencing for academic researchers to advance immune system understanding. ✔️ High-resolution, multi-omic data 🧬 Enrichment of the AMICA atlas 🗓️ Applications due by Oct 1, 2025 #scRNAseq #Immunai #AcademicResearch

Post attachment
Immunai avatar
Immunai@Immunaitech·5 May 2025

Our CEO @NoamSolomon1 just joined a very impressive club: @INVIVOnow’s 2025 Rising Leaders💥 This list features 30 people shaking up biotech, medtech, and global health. Proud moment for the @Immunaitech team. bit.ly/4m2eNZm

Immunai avatar
Immunai@Immunaitech·24 Apr 2025

We’re teaming up with @parkerici to build one of the largest real-world single-cell datasets. Integrated into AMICA™, this will power immune insights across cancers, accelerating discovery + reducing trial risk genengnews.com/topics/cancer…

Immunai avatar
Immunai@Immunaitech·2 Apr 2025

After leading R&D at Pfizer, Dr. Mikael Dolsten is entering a new chapter. He’s joining Immunai’s board to help advance AI-powered drug development. Read about his move and outlook on the future of biopharma via @PharmaVoice: tinyurl.com/352t6hxc

Immunai avatar
Immunai@Immunaitech·6 Mar 2025

Dr. Mikael Dolsten, a leader behind 35+ approved therapies, is bringing his expertise to Immunai’s Board. His experience in R&D and immunology will help us deepen AI’s role in drug discovery, bringing new treatments to patients faster. tinyurl.com/79c4sf4v

Post attachment